Do you have:
- Celiac Disease
- Inflammatory Bowel Disease (IBD)
- Recurrent Clostridioides difficile infection (CDI)
- Ulcerative Colitis (UC)
Jaffrey Kazi, MD is participating in a number of national research studies focused on developing new understandings and treatments for each of these conditions. We invite you to learn more about registry studies and drug trials to help advance gastroenterology health.
Following are current trials. If you’re interested, talk with Dr. Kazi during your next visit or go to www.aaraclinicalresearch.com/participate-today or email trial.info@azarthritis.com
Ulcerative Colitis – ABTECT-2
This study is looking at how safe an investigational medication is and whether it reduces symptoms in people with UC. If you take part, you will be in the ABTEECT-2 Study for up to 16 weeks. Those who may qualify may receive:
- Compensation for study-related travel expenses
- Reimbursement for study-related travel
- Study-related care from local doctors
- Study medication at no cost
Inflammatory Bowel Disease Registry – CorEvitas
Questionnaires will be completed during routine clinical encounters with your provider. It only takes about 10 minutes to complete the survey every six months.
Inflammatory Bowel Disease Biorepository – CorEvitas
In addition to the registry, you can choose to be part of the biorepository as well. In addition to the 10-minute survey, the blood sample collection will only take another 10 minutes to complete. Scientists use this information to learn more about health conditions and their treatments in the real world.
Restorative303 – Vendanta Biosciences
Clinical research study exploring an investigational drug to restore the microbiome (the bacteria that live in your gut) in people with recurrent CDI.
CLUES-UC – Eli Lilly
An observational study gathering outcomes from patients taking biologic medication to alleviate active moderate to severe ulcerative colitis.
MT4808 Celiac Disease – MT Group
For patients with a confirmed Celiac Disease diagnosis.
